Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2012 Nov;87(11):1089-97.
doi: 10.1016/j.mayocp.2012.07.018. Epub 2012 Oct 8.

A double-blind randomized controlled trial of continuous intravenous Ketorolac vs placebo for adjuvant pain control after renal surgery

Affiliations
Randomized Controlled Trial

A double-blind randomized controlled trial of continuous intravenous Ketorolac vs placebo for adjuvant pain control after renal surgery

Gwen M Grimsby et al. Mayo Clin Proc. 2012 Nov.

Abstract

Objective: To evaluate the efficacy and safety of a novel, continuous intravenous infusion of ketorolac, a powerful nonopioid analgesic, for postoperative pain control.

Patients and methods: A prospective, double-blind, randomized, placebo-controlled trial of a continuous infusion of ketorolac tromethamine in 1 L of normal saline vs placebo was performed in 135 patients aged 18 to 75 years after laparoscopic donor nephrectomy or percutaneous nephrolithotomy completed from October 7, 2008, through July 21, 2010. Primary study end points were the 24-hour differences in visual analog pain scores and total narcotic consumption, whereas secondary end points were differences in urine output, serum creatinine level, and hemoglobin level.

Results: The study was stopped after randomization of 135 patients (68 in the ketorolac group and 67 in the placebo group) when interim analysis indicated that the difference in mean pain scores between the 2 groups (difference, 0.6) was smaller than the 1-point threshold set forth in the power calculations. No statistically significant change was noted in hemoglobin levels from preoperative to postoperative values (P=.13) or in postoperative serum creatinine levels (P=.13).

Conclusion: Although continuous infusion of ketorolac produced only a modest decrease in the use of narcotics, it appears to offer a safe therapeutic option for nonnarcotic pain control.

Trial registration: clinicaltrials.gov Identifiers: NCT00765128 and NCT00765232.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Visual analog scale (top) and pain control algorithm (bottom).
FIGURE 2
FIGURE 2
Flowchart of randomized controlled trial of ketorolac vs placebo for pain after renal surgery. LDN = laparoscopic donor nephrectomy; PNL = percutaneous nephrolithotomy.
FIGURE 3
FIGURE 3
Mean pain score in first 24 hours.

Similar articles

Cited by

References

    1. Palvin D.J., Chen C., Penaloza D.A., Polissar N.L., Buckley F.P. Pain as a factor complicating recovery and discharge after ambulatory surgery. Anesth Analg. 2002;95(3):627–634. - PubMed
    1. Knight M.K., DiMarco D.S., Myers R.P. Subjective and objective comparison of critical care pathways for open donor nephrectomy. J Urol. 2002;167(6):2368–2371. - PubMed
    1. Carr D.B., Jacox A.K., Chapman C.R. Acute Pain Management: Operative or Medical Procedures and Trauma: Clinic Practice Guideline. Agency for Health Care Policy and Research, Public Health Service, US Dept of Health and Human Services; Rockville, MD: 1992.
    1. Ready L.B., Brown C.R., Stahlgren L.H. Evaluation of intravenous ketorolac administered by bolus or infusion for treatment of postoperative pain: a double-blind, placebo-controlled, multicenter study. Anesthesiology. 1994;80(6):1277–1286. - PubMed
    1. Breda A., Bui M., Liao J., Schulam P.G. Association of bowel rest and ketorolac analgesia with short hospital stay after laparoscopic donor nephrectomy. Urology. 2007;69(5):828–831. - PubMed

Publication types

Associated data